{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:24:45Z","timestamp":1786980285660,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"S4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s00508-008-1071-9","type":"journal-article","created":{"date-parts":[[2008,12,9]],"date-time":"2008-12-09T04:20:55Z","timestamp":1228796455000},"page":"15-19","source":"Crossref","is-referenced-by-count":18,"title":["Japanese encephalitis and vaccines: past and future prospects","Japanische Enzephalitis und Impfstoffe: R\u00fcck- und Ausblick"],"prefix":"10.1007","volume":"120","author":[{"given":"Maria","family":"Paulke-Korinek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herwig","family":"Kollaritsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"1071_CR1","volume-title":"ICTVdB \u2013 The Universal Virus Database, version 4. Edition","author":"H-J Thiel","year":"2006","unstructured":"Thiel H-J, Collett MS, Gould EA, Heinz FX, Houghton M, Meyers G, et al (2006) Index of viruses \u2013 flaviviridae in ICTVdB \u2013 The Universal Virus Database, version 4. Edition B\u00fcchen-Osmond C (ed). Columbia University, New York"},{"key":"1071_CR2","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/JVI.77.5.3091-3098.2003","volume":"77","author":"T Solomon","year":"2003","unstructured":"Solomon T, Ni H, Beasley DWC, Ekkelenkamp M, Cardosa MJ, Barrett ADT (2003) Origin and evolution of Japanese Encephalitis virus in southeast Asia. J Virol 77: 3091\u20133098","journal-title":"J Virol"},{"key":"1071_CR3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0042-6822(87)90144-9","volume":"161","author":"H Sumiyoshi","year":"1987","unstructured":"Sumiyoshi H, Mori C, Fuke I, Morita K, Kuhara S, Kondou J, et al (1987) Complete nucleotide sequence of the Japanese Encephalitis virus genome RNA. Virology 161: 497\u2013510","journal-title":"Virology"},{"key":"1071_CR4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1708-8305.2007.00134.x","volume":"14","author":"A Oya","year":"2007","unstructured":"Oya A, Kurane I (2007) Japanese Encephalitis for a reference to international travelers. J Travel Med 14: 259\u2013268","journal-title":"J Travel Med"},{"key":"1071_CR5","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1128\/JVI.73.7.5527-5534.1999","volume":"73","author":"E Konishi","year":"1999","unstructured":"Konishi E, Yamaoka M, Khin Sane W, Kurane I, Takada K, Mason PW (1999) The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese Encephalitis virus premembrane and envelope genes. J Virol 73: 5527\u20135534","journal-title":"J Virol"},{"key":"1071_CR6","unstructured":"Halstead SB, Jacobsen J (2008) Japanese Encephalitis vaccines. In: Plotkin SA, Orenstein WA, Offit P (eds) Vaccines, Edition 4. Saunders Elsevier, pp 311\u2013352"},{"key":"1071_CR7","first-page":"1","volume":"42","author":"Centers for Disease Control and Prevention","year":"1993","unstructured":"Centers for Disease Control and Prevention (1993) Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 42: 1\u201315","journal-title":"MMWR Recomm Rep"},{"key":"1071_CR8","doi-asserted-by":"crossref","first-page":"742","DOI":"10.4269\/ajtmh.1964.13.742","volume":"13","author":"DJ Gould","year":"1964","unstructured":"Gould DJ, Byrne RJ, Hayes DE (1964) Experimental infection of horses with Japanese Encephalitis virus by mosquito bite. Am J Trop Med Hyg 13: 742\u2013746","journal-title":"Am J Trop Med Hyg"},{"key":"1071_CR9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.0269-283x.2001.00324.x","volume":"15","author":"IP Sunish","year":"2001","unstructured":"Sunish IP, Reuben R (2001) Factors influencing the abundance of Japanese encephalitis vectors in rice fields in India \u2013 I. Abiotic. Med Vet Entomol 15: 381\u2013392","journal-title":"Med Vet Entomol"},{"key":"1071_CR10","first-page":"331","volume":"81","author":"WHO","year":"2006","unstructured":"WHO (2006) Japanese Encephalitis vaccines: WHO position paper. Weekly Epidemiological Record 81: 331\u2013340","journal-title":"Weekly Epidemiological Record"},{"key":"1071_CR11","unstructured":"WHO www.who.int\/vaccine_research\/diseases\/vector\/en\/index1.html (download on: 9. 7. 2008)"},{"key":"1071_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0264-410X(00)00037-2","volume":"18","author":"TF Tsai","year":"2000","unstructured":"Tsai TF (2000) New initiatives for the control of Japanese encephalitis by vaccination: Minutes of a WHO\/CVI meeting, Bangkok, Thailand, 13\u201315 October 1998. Vaccine 18: 1\u201325","journal-title":"Vaccine"},{"key":"1071_CR13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.5694\/j.1326-5377.1999.tb127878.x","volume":"170","author":"J Hanna","year":"1999","unstructured":"Hanna J, Ritchie S, Phillips D, Lee J, Hills S, van den Hurk A, et al (1999) Japanese encephalitis in north Queensland, Australia, 1998. Med J Aust 170: 533\u2013536","journal-title":"Med J Aust"},{"key":"1071_CR14","unstructured":"WHO \u2013 SEARO (2005) www.searo.who.int\/en\/section1226\/section2073.asp (download on: 9.7. 2008)"},{"key":"1071_CR15","unstructured":"WHO (2005) www.wpro.who.int\/NR\/rdonlyres\/A62D4A75-0C28-4093-95CF-555CE379C469\/0\/MTGRPT_BiregionalJE2005.pdf (download on: 10. 7. 2008)"},{"key":"1071_CR16","first-page":"237","volume":"73","author":"A Gajanana","year":"1995","unstructured":"Gajanana A, Thenmozhi V, Samuel PP, Reuben R (1995) A community-based study of subclinical flavivirus infections in children in an area of Tamil Nadu, India, where Japanese Encephalitis is endemic. Bull World Health Organ 73: 237\u2013244","journal-title":"Bull World Health Organ"},{"key":"1071_CR17","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(96)91070-3","volume":"347","author":"MC Steinhoff","year":"1996","unstructured":"Steinhoff MC (1996) Japanese Encephalitis: a Chinese solution? Lancet 347: 1570\u20131571","journal-title":"Lancet"},{"key":"1071_CR18","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(08)60238-X","volume":"371","author":"EA Gould","year":"2008","unstructured":"Gould EA, Solomon T (2008) Pathogenic flaviviruses. The Lancet 371: 500\u2013509","journal-title":"The Lancet"},{"key":"1071_CR19","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(03)12709-2","volume":"361","author":"T Solomon","year":"2003","unstructured":"Solomon T, Dung NM, Wills B, Kneen R, Gainsborough M, Diet TV, et al (2003) Interferon alfa-2a in Japanese Encephalitis: a randomised double-blind placebo-controlled trial. The Lancet 361: 821\u2013826","journal-title":"The Lancet"},{"key":"1071_CR20","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJMp058263","volume":"355","author":"T Solomon","year":"2006","unstructured":"Solomon T (2006) Control of Japanese Encephalitis \u2013 within our grasp? N Engl J Med 355: 869\u2013871","journal-title":"N Engl J Med"},{"key":"1071_CR21","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(07)61780-2","volume":"370","author":"E Tauber","year":"2007","unstructured":"Tauber E, Kollaritsch H, Korinek M, Rendi-Wagner P, Jilma B, Firbas C, et al (2007) Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese Encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial. The Lancet 370: 1847\u20131853","journal-title":"The Lancet"},{"key":"1071_CR22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1442-200X.1988.tb02516.x","volume":"30","author":"A Oya","year":"1988","unstructured":"Oya A (1988) Japanese Encephalitis vaccine. Acta Paediatr Jpn 30: 175\u2013184","journal-title":"Acta Paediatr Jpn"},{"key":"1071_CR23","doi-asserted-by":"crossref","unstructured":"Schioler KL, Samuel M, Wai KL (2007) Vaccines for preventing Japanese Encephalitis (Review). Cochrane Database Syst Rev 1\u201344","DOI":"10.1002\/14651858.CD004263.pub2"},{"key":"1071_CR24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1586\/14760584.7.5.689","volume":"7","author":"T Jelinek","year":"2008","unstructured":"Jelinek T (2008) Japanese Encephalitis vaccine in travelers. Expert Rev Vaccines 7: 689\u2013693","journal-title":"Expert Rev Vaccines"},{"key":"1071_CR25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/biol.2002.0345","volume":"30","author":"K Sugawara","year":"2002","unstructured":"Sugawara K, Nishiyama K, Ishikawa Y, Abe M, Sonoda K, Komatsu K, et al (2002) Development of vero cell-derived inactivated Japanese Encephalitis vaccine. Biologicals 30: 303\u2013314","journal-title":"Biologicals"},{"key":"1071_CR26","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1034\/j.1398-9995.2001.056006536.x","volume":"56","author":"M Sakaguchi","year":"2001","unstructured":"Sakaguchi M, Miyazawa H, Inouye S (2001) Specific IgE and IgG to gelatin in children with systemic cutaneous reactions to Japanese Encephalitis vaccines. Allergy 56: 536\u2013539","journal-title":"Allergy"},{"key":"1071_CR27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/978-3-7091-6775-5","volume-title":"Leitfaden f\u00fcr Schutzimpfungen","author":"H Kollaritsch","year":"2000","unstructured":"Kollaritsch H (2000) Japan-B-Encephalitis. In: Kollaritsch H, Wiedermann G (eds) Leitfaden f\u00fcr Schutzimpfungen. Springer, Wien New York, pp 240\u2013246"},{"key":"1071_CR28","first-page":"242","volume":"28","author":"WHO","year":"2005","unstructured":"WHO (2005) Global Advisory Committee on Vaccine Safety, 9\u201310 June 2005. Weekly Epidemiological Record 28: 242\u2013243","journal-title":"Weekly Epidemiological Record"},{"key":"1071_CR29","unstructured":"Ya\u00efch M, Jacobson J (2007) whqlibdoc.who.int\/hq\/2007\/WHO_IVB_07.10_eng.pdf (download on: 11.7. 2008)"},{"key":"1071_CR30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S1474-4422(08)70004-8","volume":"7","author":"T Solomon","year":"2008","unstructured":"Solomon T (2008) New vaccines for Japanese Encephalitis. Lancet Neurol 7: 116\u2013118","journal-title":"Lancet Neurol"},{"key":"1071_CR31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/biol.1998.0153","volume":"26","author":"WHO","year":"1998","unstructured":"WHO (1998) WHO Requirements for the use of animal cells and in vitro substrates for the production of biologicals (Requirements for Biological Substances No 50). Biologicals 26: 175\u2013193","journal-title":"Biologicals"},{"key":"1071_CR32","unstructured":"GAVI Applied Strategies (June 2008) www.gavialliance.org\/resources\/18_JE_Landscape_Jun08.pdf (download on: 9.7.2008)"},{"key":"1071_CR33","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1016\/j.vaccine.2006.12.046","volume":"25","author":"A Lyons","year":"2007","unstructured":"Lyons A, Kanesa-thasan N, Kuschner RA, Eckels KH, Putnak R, Sun W, et al (2007) A phase 2 study of a purified, inactivated virus vaccine to prevent Japanese Encephalitis. Vaccine 25: 3445\u20133453","journal-title":"Vaccine"},{"key":"1071_CR34","unstructured":"Intercell www.intercell.co.at\/SelectMenu.wa?seIDM=7FEF900D-F23A-47E1-8DEA-30E27BA97242 (download on: 10.7.2008)"},{"key":"1071_CR35","unstructured":"Presseportal (2006) www.presseportal.de (download on: 15.2.2008)"},{"key":"1071_CR36","unstructured":"Acambis www.acambis.co.uk\/default.asp?id=1917 (download on: 15.2.2008)"},{"key":"1071_CR37","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/378356","volume":"188","author":"T Monath","year":"2003","unstructured":"Monath T, Guirakhoo F, Nichols R, Yoksan S, Schrader R, Murphy C, et al (2003) Chimeric live, attenuated vaccine against Japanese Encephalitis (ChimeriVax\u2122-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese Encephalitis antigen. J Infect Dis 188: 1213\u20131230","journal-title":"J Infect Dis"},{"key":"1071_CR38","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0264-410X(01)00457-1","volume":"20","author":"TP Monath","year":"2002","unstructured":"Monath TP, McCarthy K, Bedford P, Johnson CT, Nichols R, Yoksan S, et al (2002) Clinical proof of principle for ChimeriVax\u2122-JE: Recombinant live, attenuated vaccines against flavivirus infections. Vaccine 20: 1004\u20131018","journal-title":"Vaccine"},{"key":"1071_CR39","unstructured":"Clinicaltrials.gov www.clinicaltrials.gov\/ct2\/show\/NCT00621764?term=chimerivax-je&rank=2 (download on: 10.7. 2008)"},{"key":"1071_CR40","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4269\/ajtmh.2006.75.659","volume":"75","author":"M Reid","year":"2006","unstructured":"Reid M, Mackenzie D, Baron A, Lehmann N, Lowry KYM, Aaskov J, et al (2006) Experimental infection of culex annulirostris, cluex gelidus, and aedes vigilax with a yellow fever\/Japanese Encephalitis vaccine chimera (ChimeriVax\u2122-JE). Am J Trop Med Hyg 75: 659\u2013663","journal-title":"Am J Trop Med Hyg"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-008-1071-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-008-1071-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-008-1071-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T10:59:12Z","timestamp":1589367552000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-008-1071-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":40,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["1071"],"URL":"https:\/\/doi.org\/10.1007\/s00508-008-1071-9","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}